Tech Company Inital Public Offerings
Insys Therapeutics IPO
Headquartered in Chandler, Insys Therapeutics is now a public company.
Transaction Overview
Company Name
Announced On
5/3/2013
Transaction Type
IPO
Amount
$32,000,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1333 S Spectrum Blvd. 100
Chandler, AZ 85286
USA
Chandler, AZ 85286
USA
Phone
Website
Email Address
Not Recorded
Overview
Insys Therapeutics is a specialty pharmaceutical company that develops and commercializes innovative supportive care products.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Saeed Motahari
Chief Financial Officer
Andrew Long
Vice President
Sanga Emmanuel
Vice President
Ariyapadi Krishnaraj
VP - Bus. Development
Vikram Malhotra
VP - General Counsel
Franc Fosse
VP - Human Resources
Carol Summersgill
VP - R & D
Venkat Goskonda
VP - Regulatory Affairs
Steve Sherman
Browse more venture capital transactions:
Prev: 5/3/2013: Poppin venture capital transaction
Next: 5/3/2013: AltheRx Pharmaceuticals venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are derived from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs